AETHLON MEDICAL INC (AEMD)
US00808Y4061 - Common Stock
The trading volume of these stocks is deviating from the norm in today's session.
The trading volume of these stocks is deviating from the norm in today's session.
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Top movers analysis in the middle of the day on 2024-12-19: top gainers and losers in today's session.
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
The session on Thursday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 19, 2024) - Investorideas.com, a go-to investing platform, releases the ...
Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Aethlon Medical to Present at Virtual Investor Conferences in September
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Innovation Driving Cancer's Solid Tumors Market
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 17, 2024) - Investorideas.com, a go-to investing platform, releases the...
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
AEMD Stock Earnings: Aethlon Medical Misses EPS for Q1 2025
AEMD stock results show that Aethlon Medical missed analyst estimates for earnings per share the first quarter of 2025.
AEMD Stock Earnings: Aethlon Medical Misses EPS for Q1 2025
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aethlon Medical (NASDAQ:AEMD) just reported results for the first quarter of 20...
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 12, 2024) - Investorideas.com, a go-to investing platform covering biotech and...
Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
/PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024
AEMD stock results show that Aethlon Medical beat analyst estimates for earnings per share the fourth quarter of 2024.
AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aethlon Medical (NASDAQ:AEMD) just reported results for the fourth quarter of 2...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
What's Next in Treatments for Cancer Patients with Solid Tumors?
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 20, 2024) - Investorideas.com, a go-to investing platform, releases an industry...
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out on Thursday as we break down all of the hottest stock market news this morning!